Lv31
370 积分 2021-01-10 加入
The cost–effectiveness of zolbetuximab in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma
5个月前
已完结
CDK4/6 inhibitors in drug-induced liver injury: a pharmacovigilance study of the FAERS database and analysis of the drug–gene interaction network
7个月前
已完结
Outcomes of high-grade immune checkpoint inhibitor hepatitis in hospitalized and non-hospitalized patients
8个月前
已完结
Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A Pharmacovigilance-Pharmacokinetic Appraisal
8个月前
已完结
The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration adverse event reporting system (FAERS)
10个月前
已完结
Subdural hematoma in a patient taking imatinib for GIST
10个月前
已完结
Role of Hepatitis B Surface Antibodies in Risk for Hepatitis B Virus Reactivation During Anti-Tumor Necrosis Factor Therapy
10个月前
已完结
A prospective study of preemptive tenofovir disoproxil fumarate therapy in HBsAg-positive diffuse large B cell lymphoma patients receiving R-CHOP
11个月前
已完结
Hepatotoxicity Associated with Immune Checkpoint Inhibitors in Clinical Practice: A Study Leveraging Data from the US Food and Drug Administration's Adverse Event Reporting System
11个月前
已完结
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
11个月前
已完结
皖公网安备34019202002308
